查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1758217

全球血管腹部主动脉血管瘤（AAA）市场

Endovascular Abdominal Aortic Aneurysm (AAA)
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 275 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球血管腹部主动脉血管瘤(AAA) 市场规模将达到 38 亿美元

2024年，全球血管腹部主动脉血管瘤(AAA) 市场规模估计为30亿美元，预计到2030年将达到38亿美元，2024年至2030年的复合年增长率为4.1%。血管支架是本报告分析的细分市场之一，预计其复合年增长率为4.7%，到分析期结束时市场规模将达到27亿美元。合成移植物细分市场在分析期间的复合年增长率估计为2.6%。

美国市场规模估计为 8.069 亿美元，中国市场预计复合年增长率为 7.6%

预计2024年美国血管腹部主动脉血管瘤(AAA) 市场规模将达8.069亿美元。作为世界第二大经济体，中国市场规模预计将在2030年达到7.738亿美元，在分析期间（2024-2030年）的复合年增长率为7.6%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为1.6%和3.2%。在欧洲，预计德国市场的复合年增长率为2.4%。

全球血管腹部主动脉血管瘤（AAA）市场－主要趋势与驱动因素摘要

哪些技术变革将重新定义 AAA 治疗格局？

腹部主动脉血管瘤(AAA) 的治疗正经历从开放性手术修復到微创技术的模式转移，主要代表是血管内动脉瘤修復 (EVAR)。血管支架设计、导管输送系统和影像引导方面的技术进步，使 EVAR 成为许多高所得医疗保健系统中的主要治疗方法。 EVAR 技术的核心是一种模组化血管支架，它可透过股动脉引入并精确放置在动脉瘤部位，从而有效地将薄弱的血管壁从体循环中隔离出来。向经皮、无缝线入路和低剖面设备的转变显着扩大了可治疗的患者群体，包括那些手术风险高的患者。

下一代EVAR系统着重解剖适应性和长期密封性能。栅栏式和分叉式血管内技术的发展使外科医生能够治疗曾被认为不适合传统EVAR的短颈、成角颈或浸润性内臟分支的动脉瘤。聚合物密封环、可复位移植物和整合成像标记等技术创新解决了内漏、移位和入路问题等常见併发症。此外，包括3D融合成像和机器人辅助导航在内的术中影像系统的出现，提高了手术精度，并减少了显影剂和放射线暴露。这些技术进步不仅优化了治疗效果，也影响全球治疗指南和外科医师的偏好。

哪些患者人口统计和风险状况推动了临床需求？

腹部主动脉血管瘤的负担正在加重，这主要是由于世界人口老化以及吸烟、高血压和高血脂症等可改变风险因素的普遍存在。腹主动脉瘤最常见于65岁或以上的男性，但流行病学研究也越来越多地认识到其在老年女性中的发生率。因此，一些已开发国家已经实施了针对高风险族群的筛检计划，尤其是65岁或以上的男性吸烟者。超音波筛检的广泛应用使得无症状性动脉瘤的早期发现成为可能，从而扩大了在动脉瘤破裂前接受EVAR治疗的患者群体。

对于手术风险较高的族群，例如老年患者和患有慢性阻塞性肺病(COPD)、肾功能不全和冠状动脉疾病等併发症的患者，EVAR 是传统开放性手术的可行治疗方法。这导致三级医院、门诊手术中心甚至专门从事血管介入的混合手术室的需求增加。此外，由于移植物退化和动脉瘤囊扩大，越来越多的患者在初次 EVAR 后需要再次干预，这为更新、更耐用的移植物技术创造了第二个需求管道。儘管解剖学差异对通用设备的适用性构成了挑战，但将女性纳入 AAA 风险分层方案和偶然的动脉瘤影像学发现也促进了该手术的发展。

区域生态系和市场进入如何影响采用？

北美和西欧仍然是EVAR最成熟的市场，这得益于其高手术量、先进的医院基础设施以及优惠的报销政策。美国在应用EVAR方面处于领先地位，这得益于大型医疗设备製造商的存在、正在进行的临床试验以及熟练的血管外科手术团队。在欧洲，德国、英国和荷兰等国家已展现出其公共医疗体系中强大的手术整合能力，EVAR占择期AAA修復手术的70%以上。在这些地区，政府资助的筛检倡议进一步支持了患者识别和转介至血管内治疗。

亚太地区正逐渐成为重要的成长前沿，尤其是在日本、中国和韩国。老化和都市化导致这些地区血管疾病发生率上升。日本在技术应用方面一直处于领先地位，拥有丰富的手术经验，并广泛采用客製化栅栏式器械。在中国，不断扩大的医疗基础设施和不断发展的国内器械製造商正在推动市场快速扩张。然而，报销差距和培训不足仍然是许多新兴国家面临的挑战。在拉丁美洲和中东部分地区，技术应用速度较慢，但正在成长，尤其是在服务高所得患者群体的私人医院。设备租赁、手术培训计画和混合手术室设置支援等打入市场策略已被证明在这些技术应用不足的地区行之有效。

推动 EVAR 市场成长的关键因素有哪些？

血管腹部主动脉血管瘤(AAA) 市场的成长受到多种因素的驱动，这些因素影响全球技术发展、手术普及率和患者就诊机会。其中最主要的是全球动脉瘤盛行率的不断上升，而人口老化、生活方式相关的风险因素以及筛检的扩大进一步加剧了这一趋势。随着无症状性动脉瘤的早期发现率不断提高，选择性 EVAR 作为一种比开放性手术更安全、创伤更小的替代方法，正日益受到青睐。这种转变得益于血管支架系统的持续创新，即使在解剖结构复杂的病例中，该系统的贴合性、密封性和耐用性也得到了改善。

监管趋势和支付方结构也推动了成长。 FDA核准了下一代设备，CE 标誌也扩展到涵盖先进的栅栏式和分叉式解决方案，这推动了传统和小众解剖领域的临床应用不断增加。向价值导向的医疗保健模式转变与 EVAR 较低的併发症率、较短的住院时间和较低的术后发病率相契合。医院和外科中心正在投资混合手术室和整合影像系统来支援这些手术，这表明他们对血管内介入治疗的长期效用充满信心。

此外，该行业越来越重视培训和教育，推出基于模拟的程序和全球外科医生网络，以实现手术专业知识的标准化。远端医疗的追踪和穿戴式装置的术后后续观察相结合，进一步丰富了治疗生态系统。同时，研发投入的不断增加，尤其是在生物可吸收移植组件和人工智慧成像工具方面的投入，显示 EVAR 技术仍处于活跃的进化阶段。这些多方面的因素将推动手术量和设备创新的持续成长，并牢固确立 EVAR 在可预见的未来作为 AAA 治疗的主导治疗方法。

部分

产品类型（血管支架、合成移植物）；最终使用者（医院最终使用者、门诊手术中心最终使用者、其他最终使用者）

受访公司范例（41家值得关注的公司）

  • Abbott Laboratories
  • Artivion Inc.
  • Bentley InnoMed GmbH
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Braile Biomedica
  • Cardinal Health Inc.
  • Cook Medical LLC
  • Cordis Corporation
  • CryoLife Inc.
  • Edwards Lifesciences Corp.
  • Endologix LLC
  • Getinge AB
  • JOTEC GmbH
  • LeMaitre Vascular Inc.
  • Lifetech Scientific Corp.
  • Lombard Medical Ltd.
  • Medtronic plc
  • MicroPort Scientific Corp.
  • Terumo Corporation

人工智慧集成

我们正在利用可操作的专家内容和人工智慧工具来改变市场和竞争情报。

Global Industry Analysts 并未遵循查询 LLM 或特定产业SLM 的典型规范，而是建立了一个来自全球领域专家的精选内容库，其中包括视讯录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP36838

Global Endovascular Abdominal Aortic Aneurysm (AAA) Market to Reach US$3.8 Billion by 2030

The global market for Endovascular Abdominal Aortic Aneurysm (AAA) estimated at US$3.0 Billion in the year 2024, is expected to reach US$3.8 Billion by 2030, growing at a CAGR of 4.1% over the analysis period 2024-2030. Stent Graft, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$2.7 Billion by the end of the analysis period. Growth in the Synthetic Fabric Graft segment is estimated at 2.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$806.9 Million While China is Forecast to Grow at 7.6% CAGR

The Endovascular Abdominal Aortic Aneurysm (AAA) market in the U.S. is estimated at US$806.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$773.8 Million by the year 2030 trailing a CAGR of 7.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 3.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.4% CAGR.

Global Endovascular Abdominal Aortic Aneurysm (AAA) Market - Key Trends & Drivers Summarized

What Technological Shifts Are Redefining the Treatment Landscape for AAA?

The management of abdominal aortic aneurysms (AAA) has seen a paradigm shift from open surgical repair to minimally invasive techniques, primarily led by endovascular aneurysm repair (EVAR). Technological advancements in stent graft design, catheter delivery systems, and imaging guidance have enabled EVAR to become the dominant intervention method in many high-income healthcare systems. The core of EVAR technology lies in modular stent grafts that can be introduced via femoral artery access and deployed precisely at the aneurysm site, effectively excluding the weakened vessel wall from systemic circulation. The shift toward percutaneous, suture-less access and low-profile devices has significantly expanded the treatable patient population, including those with higher surgical risk.

Next-generation EVAR systems are emphasizing anatomical adaptability and long-term sealing performance. The development of fenestrated and branched endografts has allowed surgeons to treat aneurysms that were once considered unsuitable for conventional EVAR due to short or angulated necks, or involvement of visceral branches. Innovations such as polymer-based sealing rings, repositionable grafts, and integrated imaging markers are addressing common complications like endoleaks, migration, and access issues. Additionally, the emergence of intraoperative imaging systems, including 3D fusion imaging and robotic-assisted navigation, is streamlining procedural accuracy and reducing contrast and radiation exposure. These technological strides are not only optimizing procedural outcomes but also influencing treatment guidelines and surgeon preferences globally.

Which Patient Demographics and Risk Profiles Are Driving Clinical Demand?

The burden of abdominal aortic aneurysms is rising, largely influenced by the aging global population and prevalence of modifiable risk factors such as smoking, hypertension, and hyperlipidemia. AAAs are most commonly diagnosed in men aged 65 and older, though incidence among older women is increasingly recognized in epidemiological studies. As a result, screening programs have been introduced in several developed countries targeting at-risk populations, particularly male smokers over the age of 65. The broader implementation of ultrasound-based screening has led to earlier detection of asymptomatic aneurysms, thus expanding the pool of patients eligible for elective EVAR procedures before rupture occurs.

In high-risk surgical populations-such as the elderly or those with comorbidities like chronic obstructive pulmonary disease (COPD), renal dysfunction, or coronary artery disease-EVAR offers a viable treatment alternative to traditional open repair. This has driven demand across tertiary hospitals, ambulatory surgical centers, and even hybrid operating rooms tailored for vascular interventions. Furthermore, the growing number of patients requiring reintervention after initial EVAR due to graft degeneration or aneurysm sac enlargement is creating a secondary demand channel for newer, more durable graft technologies. The inclusion of women in AAA risk stratification protocols and the detection of aneurysms through incidental imaging are also contributing to procedural growth, though anatomical differences still pose challenges for universal device applicability.

How Are Regional Ecosystems and Market Access Influencing Uptake?

North America and Western Europe remain the most mature markets for EVAR, driven by high procedural volumes, advanced hospital infrastructure, and favorable reimbursement policies. The U.S. has been a leading adopter of EVAR, supported by the presence of major medical device manufacturers, continuous clinical trials, and a skilled vascular surgery workforce. In the European context, countries like Germany, the UK, and the Netherlands demonstrate strong procedural integration within public health systems, with EVAR accounting for over 70% of elective AAA repairs. Government-funded screening initiatives in these regions further fuel patient identification and referral for endovascular treatment.

Asia-Pacific is emerging as a key growth frontier, particularly in Japan, China, and South Korea, where the aging population and urbanization are increasing the incidence of vascular diseases. Japan has been at the forefront in terms of technological adoption, with robust procedural experience and widespread use of custom fenestrated devices. In China, expanding healthcare infrastructure and the development of domestic device manufacturers are enabling rapid market expansion. However, reimbursement disparities and training limitations remain challenges in many emerging economies. In Latin America and parts of the Middle East, adoption is slower but growing, especially in private hospitals catering to higher-income patient segments. Market access strategies such as device leasing, surgical training programs, and hybrid OR installation support are proving effective in these underpenetrated regions.

What Are the Key Forces Powering the Growth of the EVAR Market?

The growth in the endovascular abdominal aortic aneurysm (AAA) market is driven by several factors that collectively shape technology development, procedural adoption, and patient access worldwide. Chief among them is the increasing global prevalence of AAAs, a trend exacerbated by demographic aging, lifestyle-related risk factors, and expanded screening practices. As asymptomatic aneurysms are increasingly detected at an earlier stage, elective EVAR is being prioritized as a safer, less invasive alternative to open surgery. This shift is underpinned by continued innovation in stent graft systems that offer enhanced conformability, sealing capacity, and durability, even in anatomically complex cases.

Regulatory pathways and payer structures are also accelerating growth. With FDA approvals for next-gen devices and CE marks expanding to cover advanced fenestrated and branched solutions, clinical adoption is rising in both traditional and niche anatomical segments. The movement toward value-based healthcare models is aligning well with EVAR's lower complication rates, shorter hospital stays, and reduced postoperative morbidity. Hospitals and surgical centers are investing in hybrid ORs and integrated imaging systems to support these procedures, indicating confidence in the long-term utility of endovascular approaches.

Additionally, industry players are increasingly focused on training and education, launching simulation-based programs and global surgeon networks to standardize procedural expertise. The combination of telehealth for follow-up care and wearable devices for postoperative surveillance is further enriching the treatment ecosystem. Meanwhile, increasing investments in R&D-especially into bioresorbable graft components and AI-enabled imaging tools-suggest that EVAR technology is still in a phase of active evolution. These multifactorial drivers point toward sustained expansion in both procedure volumes and device innovation, firmly establishing EVAR as the dominant modality in AAA management for the foreseeable future.

SCOPE OF STUDY:

The report analyzes the Endovascular Abdominal Aortic Aneurysm (AAA) market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Stent Graft, Synthetic Fabric Graft); End-Use (Hospital End-Use, Ambulatory Surgery Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • Abbott Laboratories
  • Artivion Inc.
  • Bentley InnoMed GmbH
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Braile Biomedica
  • Cardinal Health Inc.
  • Cook Medical LLC
  • Cordis Corporation
  • CryoLife Inc.
  • Edwards Lifesciences Corp.
  • Endologix LLC
  • Getinge AB
  • JOTEC GmbH
  • LeMaitre Vascular Inc.
  • Lifetech Scientific Corp.
  • Lombard Medical Ltd.
  • Medtronic plc
  • MicroPort Scientific Corp.
  • Terumo Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Endovascular Abdominal Aortic Aneurysm (AAA) - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Aortic Aneurysms Among Aging Population Drives Demand for Endovascular Repair
    • Technological Advancements in Stent Graft Designs Propel Growth in Minimally Invasive AAA Treatments
    • Expansion of Screening Programs for Aortic Aneurysms Throws Spotlight on Early Detection and Elective Repair
    • Improved Outcomes and Lower Morbidity Rates Strengthen Business Case for Endovascular Over Open Surgery
    • Integration of 3D Imaging and Navigation Technologies Enhances Precision in Stent Graft Placement
    • Development of Fenestrated and Branched Stent Grafts Expands Addressable Patient Pool With Complex Anatomy
    • Increasing Adoption of EVAR in Ambulatory Surgical Centers Spurs Procedural Volume Growth
    • Regulatory Approvals for Next-Generation Grafts Accelerate Innovation and Clinical Uptake
    • Surge in High-Risk and Comorbid Patients Strengthens Preference for Endovascular Approaches
    • Collaboration With Vascular Surgeons Fuels Device Design Improvements and Workflow Integration
    • Clinical Data Supporting Long-Term Durability of EVAR Devices Encourages Broader Adoption
    • Growing Emphasis on Post-EVAR Surveillance Supports Demand for Follow-Up Imaging Technologies
    • Hospital Investments in Hybrid Operating Rooms Drive Multidisciplinary AAA Repair Capabilities
    • Patient Awareness Campaigns and Screening Initiatives Spur Elective Procedure Rates
    • Payer Reimbursement for Minimally Invasive Aneurysm Repairs Strengthens Financial Accessibility
    • Increasing Use of Contrast-Free and Low-Radiation Imaging Expands EVAR Safety in Renal-Impaired Patients
    • Emerging Use of AI in Aneurysm Morphology Assessment Drives Personalized Device Selection
    • Global Burden of Cardiovascular Disease Supports Government-Funded AAA Screening Programs
    • Focus on Device Miniaturization and Flexibility Enhances Access in Narrow Iliac Arteries
    • Expansion of Training and Simulation Programs Improves Vascular Surgeon Expertise in EVAR Techniques
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Endovascular Abdominal Aortic Aneurysm (AAA) Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Stent Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Stent Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Stent Graft by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Synthetic Fabric Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Synthetic Fabric Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Synthetic Fabric Graft by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospital End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospital End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Hospital End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • JAPAN
    • Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CHINA
    • Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: China 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: China 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • EUROPE
    • Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • FRANCE
    • Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: France 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: France 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • GERMANY
    • Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • INDIA
    • Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: India 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: India 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AFRICA
    • Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030

IV. COMPETITION